Thank you for the detailed answer to my question about MSC legitimacy. Your answer is one I expected and respect. MS sufferers are still wondering why more research isn't done in this area in the USA. Is it a financial issue or is there much being done but we just don't hear about it? Loaded question, do you see a solution in the near future? Thanks again.
There are 3 main limitations to Mesenchymal Stem Cell research for MS in the United States:
- Scientific investigation in academic centers requires investigators to apply for and receive an investigational new drug (IND) and Biologic License Application (BLA) from the Food and Drug administration. Some investigators have gone through this process but not many.
- Funding for such studies is limited until there is preliminary evidence of benefit.
- The intellectual property issues need to be clarified.
Revere (Rip) Kinkel MD
Director of the Multiple Sclerosis Program
Clinical Neurosciences Director
Professor of Clinical Neurosciences
University of California San Diego